|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
CYCLOSPORINE REDUCES ITS METABOLISM, HENCE BIOAVAILABILITY OF THE DRUG IS INCREASED
|
CLARITHROMYCIN INCREASES PLASMA CONCENTRATION BY 30% AND MEAN HALF LIFE FROM 1.2 TO 1.6 HRS
|
KETOCONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
MICONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
ITRACONAZOLE REDUCES THE DRUG METABOLISM HENCE SERUM LEVELS ARE INCREASED
|
VINBLASTIN MAY REDUCE DRUG METABOLISM LEADING TO INCREASED PLASMA CONCENTRATION
|
VINBLASTIN MAY REDUCE DRUG METABOLISM LEADING TO INCREASED PLASMA CONCENTRATION
|